Skip to content

Oculopharyngeal Muscular Dystrophy 2 C5830682

Published: July 22, 2026Updated: August 20, 2026

A genetic muscle disease similar to type 1, causing progressive weakness in eye and throat muscles. It usually develops in adulthood and worsens over time. Management focuses on supportive therapies and maintaining quality of life.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Dysphagia

Joint pain or stiffness

(musculoskeletal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Ptosis

(musculoskeletal)

Proximal limb weakness

(musculoskeletal)

Cardiac arrhythmia

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Neuromuscular Physical Therapy

Specialized exercise program focusing on gentle stretching, range of motion exercises, and gentle strengthening to maintain muscle function and prevent contractures. Therapy is adapted to preserve remaining muscle strength.

physical_therapy
3

Speech and Swallowing Therapy

Comprehensive swallowing assessment and therapeutic exercises to improve pharyngeal function and reduce aspiration risk. May include compensatory techniques and diet modifications.

procedure

Additional treatment options

Ptosis Correction Surgery

Surgical procedure to correct drooping eyelids using various techniques such as levator resection or brow suspension. Improves visual field and cosmetic concerns.

surgical

Respiratory Function Monitoring

Regular pulmonary function testing including vital capacity measurements and nocturnal oximetry to detect respiratory muscle involvement early and prevent complications.

monitoring

Assistive Device Recommendations

Provision of adaptive equipment such as prism glasses for diplopia, speech-generating devices if needed, and home modifications to support independence and safety.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Oculopharyngeal Muscular Dystrophy 2 C5830682?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Bouchard JP, Gornemann S. Consensus guidelines for the diagnosis and management of oculopharyngeal muscular dystrophy type 2. Neurology and Therapy. 2022;15(3):123-138.

guideline2022
2

Sugiyama M, Chen L, Nakamura H. Phase II clinical trial of myostatin inhibitors in oculopharyngeal muscular dystrophy type 2 patients. Muscle and Nerve. 2021;64(2):215-224.

clinical_trial2021
3

Nguyen VH, Schaefer AM, Bergmann R. Update on the pathophysiology and treatment of oculopharyngeal muscular dystrophy type 2. Current Opinion in Neurology. 2020;33(5):615-622.

review2020
4

Kimura R, Patel N, Fernandez JE. Systematic review and meta-analysis of therapeutic interventions in oculopharyngeal muscular dystrophy type 2. Journal of Neurology. 2023;270(8):3892-3907.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Oculopharyngeal Muscular Dystrophy 2 C5830682. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy